The chief executive of Novartis sent employees an email Thursday seeking to contain intensifying political and business fallout over the revelation that the drug maker paid $1.2 million to President Trump’s personal lawyer to gain access to the White House.
“Yesterday was not a good day for Novartis,” wrote Vasant Narasimhan, a physician and former McKinsey consultant, who joined the drug maker more than a decade ago and oversaw global drug development before being promoted to chief executive this past February.
“Many of you have seen media reports regarding the Novartis relationship with Essential Consultants in the U.S. and many of you will feel disappointed and frustrated,” according to the email, which was shared with STAT by a Novartis employee.
About the Author Reprints
While not the best thing to happen to NVS, we should wait to see how things shake out with the new CEO on this. If involved then he should be accountable but this may all have been done without his knowledge but only time will tell. This is not the same organization I worked at years back, and something like this is not shocking, but it is much to soon to lump all executives into this right now